vs
Side-by-side financial comparison of Air Products (APD) and Globe Life (GL). Click either name above to swap in a different company.
Air Products is the larger business by last-quarter revenue ($3.2B vs $1.6B, roughly 2.0× Globe Life). Air Products runs the higher net margin — 22.9% vs 17.3%, a 5.5% gap on every dollar of revenue. On growth, Air Products posted the faster year-over-year revenue change (8.8% vs 5.3%). Over the past eight quarters, Globe Life's revenue compounded faster (4.1% CAGR vs 3.1%).
Air Products and Chemicals, Inc. provides atmospheric gases, process and specialty gases, equipment, and services worldwide. The company produces atmospheric gases, including oxygen, nitrogen, and argon; process gases, such as hydrogen, helium, carbon dioxide, carbon monoxide, syngas; specialty gases; and equipment for the production or processing of gases comprising air separation units and non-cryogenic generators for customers in various industries, including refining, chemical, gasificati...
Globe Life Inc. (GL) is an American financial services holding company listed on the New York Stock Exchange which operates through its wholly owned subsidiaries providing life insurance, annuity, and supplemental health insurance products. The company is based in McKinney, Texas.
APD vs GL — Head-to-Head
Income Statement — Q2 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $3.2B | $1.6B |
| Net Profit | $724.8M | $270.5M |
| Gross Margin | 31.1% | — |
| Operating Margin | — | — |
| Net Margin | 22.9% | 17.3% |
| Revenue YoY | 8.8% | 5.3% |
| Net Profit YoY | 166.6% | — |
| EPS (diluted) | $3.19 | $3.39 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $3.2B | $1.6B | ||
| Q4 25 | $3.1B | $1.5B | ||
| Q3 25 | $3.2B | $1.5B | ||
| Q2 25 | $3.0B | $1.5B | ||
| Q1 25 | $2.9B | $1.5B | ||
| Q4 24 | $2.9B | $1.5B | ||
| Q3 24 | $3.2B | $1.5B | ||
| Q2 24 | $3.0B | $1.4B |
| Q1 26 | $724.8M | $270.5M | ||
| Q4 25 | $678.2M | $266.1M | ||
| Q3 25 | $4.9M | $387.8M | ||
| Q2 25 | $713.8M | $252.7M | ||
| Q1 25 | $-1.7B | $254.6M | ||
| Q4 24 | $617.4M | $255.2M | ||
| Q3 24 | $1.9B | $303.0M | ||
| Q2 24 | $696.6M | $258.4M |
| Q1 26 | 31.1% | — | ||
| Q4 25 | 32.1% | — | ||
| Q3 25 | 32.3% | — | ||
| Q2 25 | 32.5% | — | ||
| Q1 25 | 29.6% | — | ||
| Q4 24 | 31.2% | — | ||
| Q3 24 | 34.0% | 26.1% | ||
| Q2 24 | 32.8% | 23.3% |
| Q1 26 | — | — | ||
| Q4 25 | 23.7% | 21.7% | ||
| Q3 25 | 0.5% | 31.5% | ||
| Q2 25 | 26.2% | 21.2% | ||
| Q1 25 | -79.8% | 21.4% | ||
| Q4 24 | 22.0% | 21.3% | ||
| Q3 24 | 76.1% | 26.3% | ||
| Q2 24 | 24.7% | 23.5% |
| Q1 26 | 22.9% | 17.3% | ||
| Q4 25 | 21.9% | 17.5% | ||
| Q3 25 | 0.2% | 25.6% | ||
| Q2 25 | 23.6% | 17.1% | ||
| Q1 25 | -59.3% | 17.2% | ||
| Q4 24 | 21.1% | 17.4% | ||
| Q3 24 | 61.2% | 20.8% | ||
| Q2 24 | 23.3% | 17.9% |
| Q1 26 | $3.19 | $3.39 | ||
| Q4 25 | $3.04 | $3.28 | ||
| Q3 25 | $0.03 | $4.73 | ||
| Q2 25 | $3.20 | $3.05 | ||
| Q1 25 | $-7.77 | $3.01 | ||
| Q4 24 | $2.77 | $3.00 | ||
| Q3 24 | $8.75 | $3.44 | ||
| Q2 24 | $3.13 | $2.83 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $183.8M |
| Total DebtLower is stronger | $17.4M | — |
| Stockholders' EquityBook value | $18.1M | $6.1B |
| Total Assets | $41.6M | — |
| Debt / EquityLower = less leverage | 0.96× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $183.8M | ||
| Q4 25 | $1.0B | $314.7M | ||
| Q3 25 | $1.9B | $62.8M | ||
| Q2 25 | $2.3B | $116.7M | ||
| Q1 25 | $1.6B | $134.1M | ||
| Q4 24 | $2.0B | $85.0M | ||
| Q3 24 | $3.0B | $100.5M | ||
| Q2 24 | $2.4B | $100.6M |
| Q1 26 | $17.4M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $18.1M | $6.1B | ||
| Q4 25 | $15.4B | $6.0B | ||
| Q3 25 | $15.0B | $5.7B | ||
| Q2 25 | $15.5B | $5.4B | ||
| Q1 25 | $14.7B | $5.4B | ||
| Q4 24 | $16.7B | $5.3B | ||
| Q3 24 | $17.0B | $4.6B | ||
| Q2 24 | $15.1B | $5.2B |
| Q1 26 | $41.6M | — | ||
| Q4 25 | $41.2B | $30.8B | ||
| Q3 25 | $41.1B | $30.5B | ||
| Q2 25 | $41.7B | $29.8B | ||
| Q1 25 | $38.9B | $29.7B | ||
| Q4 24 | $40.0B | $29.1B | ||
| Q3 24 | $39.6B | $29.6B | ||
| Q2 24 | $37.0B | $28.3B |
| Q1 26 | 0.96× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
APD
Segment breakdown not available.
GL
| Life premium | $853.2M | 55% |
| Health premium | $416.9M | 27% |
| Other | $289.5M | 19% |
